Skip to main content
Clinical Trials/CTRI/2020/09/027816
CTRI/2020/09/027816
Not yet recruiting
未知

Role of Renal Resistive Index and Biomarkers (Urine NGAL, Serum IL6) in determining the type of Acute Kidney Injury in patients of Cirrhosis

Dr Ajay Kumar0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: N179- Acute kidney failure, unspecifiedHealth Condition 2: K746- Other and unspecified cirrhosis ofliver
Sponsor
Dr Ajay Kumar
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Dr Ajay Kumar

Eligibility Criteria

Inclusion Criteria

  • Diagnosed cases of cirrhosis with AKI (\>\= Stage IB, Serum creatinine \>\= 1\.5mg/dL)

Exclusion Criteria

  • Hypertension
  • Diabetes Mellitus
  • Renovascular disease
  • Prior Kidney or Liver Tramsplant
  • Acute or Chronic Renal Replacement Therapy at the time of enrolment
  • Other causes of renal insufficiency like intrinsic causes of AKI other than ATN (like glomerulonephritis) or urinary Obstruction
  • Confirmed pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials